Search results Showing 10 of 10 results for “breast cancer”
Canada’s COVID-19 Immunity Task Force funds national CanPath study looking at seroprevalence of COVID-19 antibodies among high-risk populations
…is a unique platform that allows scientists to explore how genetics, environment, lifestyle, and behaviour interact and contribute to the development of chronic disease and cancer. CanPath is hosted by…
Characteristics of the COVID-19 pandemic and risk factors for severe infection: a population based study within the Canadian Partnership for Tomorrow's Health
…most vulnerable to severe COVID-19disease is evolving, but data suggests that increasing age, obesity, and having underlying health conditions, including heart conditions, immunocompromised state, type 2 diabetes, cancer, chronic obstructive…
Le Groupe de travail sur l'immunité face à la COVID-19 du Canada finance une étude nationale sur la séroprévalence d'anticorps propres à la COVID-19 au sein de populations très vulnérables
…aux scientifiques d’explorer les interactions entre génétique, environnement, mode de vie et comportement, ainsi que la contribution de ces facteurs au développement de maladies chroniques et du cancer. CanPath opère…
Caractéristiques de la pandémie de COVID-19 et facteurs de risque d’infection grave : une étude de population dans le cadre du Partenariat canadien pour la santé de demain
…compris les troubles cardiaques, un état d’immunodépression, le diabète de type 2, le cancer et la maladie pulmonaire obstructive chronique, exposent à un risque accru. Il existe de nombreux autres…
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
…ctDNA levels. The study found that early kinetics of cancer-specific methylation (CSM) predicted overall survival and progression-free survival, independent of tumor type, PD-L1, and tumor mutation burden. The researchers’ tumor-naïve…
CanPath Awarded $2.1 million CIHR Grant for SUPPORT-Canada COVID-19 Initiative
…Institute for Cancer Research, University Hospital Network and Mount Sinai Hospital. The CIHR grant will be awarded through the Ontario Institute for Cancer Research, which is a partner with the…
CanPath reçoit une subvention de 2,1 millions de dollars des IRSC pour l’initiative SUPPORT-Canada COVID-19
…de SUPPORT-Canada comprend des co-chercheurs de toutes les cohortes régionales de CanPath et des experts en immunologie, en génomique et en bio-banques de l’Institut ontarien de recherche sur le cancer,…
The influence of smoking and occupational risk factors on DNA methylation in the AHRR and F2RL3 genes
The researchers aimed to determine the association between smoking, occupational exposures, and AHRR and F2RL3 methylation, as AHRR and F2RL3 hypomethylation has been associated with lung cancer. A case-control study…
Polygenic Prediction of Outwardly Visible Characteristics
…as ancestry and even cancer risk. This project will uncover where biases exist in commercial algorithms that use genetic data to predict eye colour, hair colour, etc. and then build…
Early results from CanPath's national study confirm antibody levels are stronger after receiving two doses of COVID-19 vaccine
…development of chronic disease and cancer. CanPath is hosted by the University of Toronto’s Dalla Lana School of Public Health with national funding from the Canadian Partnership Against Cancer. To…